Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Semaglutide is an innovative new obesity medication that is taking the weight loss market by storm
Pancreatitis While rare in trials, GLP-1 and amylin-based therapies carry theoretical pancreatitis risk
Common side effects during the early weeks include: Nausea (the most frequently reported) Reduced appetite Mild abdominal discomfort or bloating Occasional diarrhoea or constipation These effects are usually mild to moderate and tend to diminish as the body adapts to the medication
But they almost exclusively require expensive cofactors such as NADP + , the oxidized form of the biological cofactor nicotinamide adenine dinucleotide phosphate
Amgen, Viking Therapeutics, Boehringer Ingelheim, Zealand Pharma, and Pfizer are also important watchlist companies
Read the full comparison
US$ 25.95
US$ 28.80
US$ 26.48
US$ 29.92
US$ 26.04
US$ 26.79
US$ 20.04
US$ 29.40
US$ 28.98
